| Date Filed | Type | Description |
| 08/11/2023 |
4
| GOWEN MAXINE (Director) has filed a Form 4 on Aceragen, Inc.|
Txns:
| Sold 51 shares
@ $0.51, valued at
$26 |
|
| 08/10/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 06/12/2023 |
4
| GOWEN MAXINE (Director) has filed a Form 4 on Merus N.V.|
Txns:
| Granted 14,414 options to buy
@ $23.29, valued at
$335.7k
|
|
| 06/05/2023 |
4
| GOWEN MAXINE (Director) has filed a Form 4 on Aclaris Therapeutics, Inc.|
Txns:
| Granted 15,750 options to buy
@ $8.7, valued at
$137k
Granted 4,660 restricted stock units
@ $0
Exercised 4,507 restricted stock units
@ $0 |
|
| 05/26/2023 |
4
| GOWEN MAXINE (Director) has filed a Form 4 on Passage BIO, Inc.|
Txns:
| Granted 24,000 options to buy
@ $1, valued at
$24k
|
|
| 06/27/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/02/2022 |
4
| GOWEN MAXINE (Director) has filed a Form 4 on Merus N.V.|
Txns:
| Granted 16,604 options to buy
@ $18.56, valued at
$308.2k
|
|
| 06/01/2022 |
4
| GOWEN MAXINE (Director) has filed a Form 4 on Passage BIO, Inc.|
Txns:
| Granted 40,000 options to buy
@ $1.8, valued at
$72k
|
|
| 05/31/2022 |
4
| GOWEN MAXINE (Director) has filed a Form 4 on Passage BIO, Inc.|
Txns:
| Granted 24,000 options to buy
@ $1.76, valued at
$42.2k
|
|
| 06/16/2021 |
4/A
| GOWEN MAXINE (Director) has filed a Form 4 on Merus N.V.|
Txns:
| Granted 12,240 options to buy
@ $21.15, valued at
$258.9k
|
|
| 06/10/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/04/2021 |
4
| GOWEN MAXINE (Director) has filed a Form 4 on Aclaris Therapeutics, Inc.|
Txns:
| Granted 12,250 options to buy
@ $21.9, valued at
$268.3k
Granted 3,356 restricted stock units
@ $0 |
|
| 06/02/2021 |
4
| GOWEN MAXINE (Director) has filed a Form 4 on Merus N.V.|
Txns:
| Granted 12,240 options to buy
@ $21.15, valued at
$258.9k
|
|
| 06/02/2021 |
3
| GOWEN MAXINE (Director) has filed a Form 3 on Merus N.V. |
| 06/01/2021 |
4
| GOWEN MAXINE (Director) has filed a Form 4 on Passage BIO, Inc.|
Txns:
| Granted 4,542 options to buy
@ $13.83, valued at
$62.8k
|
|
| 02/22/2021 |
4
| GOWEN MAXINE (Director) has filed a Form 4 on Passage BIO, Inc.|
Txns:
| Granted 33,836 options to buy
@ $21.46, valued at
$726.1k
|
|
| 02/22/2021 |
3
| GOWEN MAXINE (Director) has filed a Form 3 on Passage BIO, Inc. |
| 06/09/2020 |
4
| GOWEN MAXINE (Director) has filed a Form 4 on Akebia Therapeutics, Inc.|
Txns:
| Granted 13,700 shares
@ $0
Sold 4,567 shares
@ $12.05, valued at
$55k
Granted 20,100 options to buy
@ $11.96, valued at
$240.4k
|
|
| 06/08/2020 |
4
| GOWEN MAXINE (Director) has filed a Form 4 on Aclaris Therapeutics, Inc.|
Txns:
| Granted 16,500 options to buy
@ $1.41, valued at
$23.3k
|
|
| 05/19/2020 |
4
| GOWEN MAXINE (Director) has filed a Form 4 on IDERA PHARMACEUTICALS, INC.|
Txns:
| Granted 11,500 options to buy
@ $1.97, valued at
$22.7k
|
|
| 05/15/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/04/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/03/2019 |
4
| GOWEN MAXINE (Director) has filed a Form 4 on Aclaris Therapeutics, Inc.|
Txns:
| Granted 16,000 options to buy
@ $2.34, valued at
$37.4k
|
|
| 07/03/2019 |
3
| GOWEN MAXINE (Director) has filed a Form 3 on Aclaris Therapeutics, Inc. |
| 06/10/2019 |
4
| GOWEN MAXINE (Director) has filed a Form 4 on Akebia Therapeutics, Inc.|
Txns:
| Granted 13,700 shares
@ $0
Granted 20,100 options to buy
@ $4.23, valued at
$85k
|
|
| 06/06/2019 |
4
| GOWEN MAXINE (Director) has filed a Form 4 on IDERA PHARMACEUTICALS, INC.|
Txns:
| Granted 11,500 options to buy
@ $2.57, valued at
$29.6k
|
|
| 05/16/2019 |
4
| GOWEN MAXINE (Director) has filed a Form 4 on TREVENA INC|
Txns:
| Granted 30,000 options to buy
@ $1.34, valued at
$40.2k
|
|
| 02/05/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/22/2018 |
4
| GOWEN MAXINE (Director) has filed a Form 4 on IDERA PHARMACEUTICALS, INC.|
Txns:
| Granted 50,000 options to buy
@ $1.53, valued at
$76.5k
|
|
| 06/15/2018 |
4
| GOWEN MAXINE (Director) has filed a Form 4 on Akebia Therapeutics, Inc.|
Txns:
| Granted 12,500 options to buy
@ $11.14, valued at
$139.3k
|
|
| 03/02/2018 |
4
| GOWEN MAXINE (President & CEO) has filed a Form 4 on TREVENA INC|
Txns:
| Granted 150,000 options to buy
@ $1.79, valued at
$268.5k
Granted 252,500 options to buy
@ $1.79, valued at
$452k
|
|
| 08/29/2017 |
4
| GOWEN MAXINE (President & CEO) has filed a Form 4 on TREVENA INC |
| 06/19/2017 |
4
| GOWEN MAXINE (Director) has filed a Form 4 on Akebia Therapeutics, Inc.|
Txns:
| Granted 12,500 options to buy
@ $14.37, valued at
$179.6k
|
|
|